Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ANEB Anebulo Pharmaceuticals

Watchlist
2.660
-0.390-12.79%
Close  01/27 16:00 ET
2.6600.0000.00%
Post Mkt Price 01/27 19:57 ET
High
3.030
Open
3.030
Turnover
77.89K
Low
2.500
Pre Close
3.050
Volume
28.97K
Market Cap
68.19M
P/E(TTM)
Loss
52wk High
7.885
Shares
25.63M
P/E(Static)
Loss
52wk Low
1.770
Float Cap
7.79M
Bid/Ask %
-60.00%
Historical High
9.330
Shs Float
2.93M
Volume Ratio
6.76
Historical Low
1.770
Dividend TTM
--
Div Yield TTM
--
P/B
3.57
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.99%
Amplitude
17.38%
Avg Price
2.688
Lot Size
1
Float Cap
7.79M
Bid/Ask %
-60.00%
Historical High
9.330
Shs Float
2.93M
Volume Ratio
6.76
Historical Low
1.770
Dividend TTM
--
P/B
3.57
Dividend LFY
--
Turnover Ratio
0.99%
Amplitude
17.38%
Avg Price
2.688
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Anebulo Pharmaceuticals, Inc. engages in the provision of pharmaceutical services. The firm’s product candidate is ANEB-001, a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The company was founded by Joseph F. Lawler on April 23, 2020 and is headquartered in Lakeway, TX.
CEO: Mr. Simon Allen, M.B.A.
Market: NASDAQ
Listing Date: 05/07/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist